Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

DNA Sequencing

Published by: RI Technologies

Published: Feb. 1, 2008 - 402 Pages


Table of Contents


I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Introduction

DNA - An Introduction

Localization of DNA

Composition of DNA

Structure of DNA

Heredity and DNA

Definitions of Important Terms

Legend

Gene

Proteins

Translation

Circular Proteins

Inteins

Molecular Chaperones

Proteomics

DNA

Plasmid

BAC

Vector

Insert

Shotgun Sequencing

Phenotype

Genotype

History of DNA and Genome Sequencing

Discovery of DNA

DNA Sequencing

Sanger’s Method

Maxam and Gilbert Method

Pyrosequencing Method

Shot Gun Sequencing Method

Capillary Array Electrophoresis Technique

Genome Sequencing

Human Genome Project

Sequencing Mitochondrial DNA

Historical Perspective (1700-2007)

Segmentation of DNA Sequencing

Exhibit 1: Segmentation of Global DNA Sequencing Market by Methods (Automated and Non-Automated), Applications (Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics) and Instruments/Software (Instruments and Bio-informatics)

2. Global Market Analysis

Exhibit 2: DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Analysis by Method

Automated

Exhibit 3: Automated DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 4: Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World

Non-Automated

Exhibit 5: Non-Automated DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 6: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World

Analysis by Application

Medical Research

Exhibit 7: DNA Sequencing in Medical Research (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 8: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World

Agriculture & Animal Husbandry

Exhibit 9: DNA Sequencing in Agricultural and Animal Husbandry (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 10: DNA Sequencing in Agricultural and Animal Husbandry (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World

DNA Testing & Forensics

Exhibit 11: DNA Sequencing in Testing and Forensics (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 12: DNA Sequencing in Testing and Forensics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World

Analysis by Instruments/Software

Instruments

Exhibit 13: DNA Sequencing Instruments (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World US$ Billion (Graphical Representation Included)

Exhibit 14: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World

Bio-Informatics

Exhibit 15: Bio-Informatics for DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 16: Bio-Informatics for DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World

Exhibit 17: List of Major Global Companies

3. Regional Market Analysis

North America

Exhibit 18: DNA Sequencing (2005-2012) - North American Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Major Companies in North America

454 Life Sciences (USA)

Abbott Laboratories (USA)

Affymetrix, Inc. (USA)

Agencourt Bioscience Corporation (USA)

Agilent Technologies, Inc. (USA)

Applied Biosystems Group (USA)

BD Biosciences (USA)

Beckman Coulter, Inc. (USA)

BioTrove, Inc. (USA)

Cogenics (A Division of Clinical Data) (USA)

Commonwealth Biotechnologies, Inc. (USA)

Crime Scene Technologies LLC (USA)

DNA LandMarks, Inc. (Canada)

Epicentre Biotechnologies (USA)

Gene Logic, Inc. (USA)

Gen-Probe, Inc. (USA)

Helicos BioSciences Corporation (USA)

Illumina, Inc. (USA)

Integrated DNA Technologies, Inc. (USA)

Invitrogen, Inc. (USA)

Luminex Molecular Diagnostics (Canada)

Nimblegen Systems, Inc. (USA)

PrimmBiotech, Inc. (USA)

Promega Corp. (USA)

Sequetech Corp. (USA)

Third Wave Technologies, Inc. (USA)

Analysis by Method

Automated

Exhibit 19: Automated DNA Sequencing (2005-2012) -North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 20: Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Non-Automated

Exhibit 21: Non-Automated DNA Sequencing (2005-2012) -North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 22: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of the North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Analysis by Application

Medical Research

Exhibit 23: DNA Sequencing in Medical Research (2005-2012) -North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 24: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Agriculture & Animal Husbandry

Exhibit 25: DNA Sequencing in Agriculture & Animal Husbandry (2005-2012) - North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 26: DNA Sequencing Agriculture & Animal Husbandry (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

DNA Testing & Forensics

Exhibit 27: DNA Sequencing in Testing and Forensics (2005-2012) -North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 28: DNA Sequencing Testing and Forensics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Analysis by Instruments/Software

Instruments

Exhibit 29: DNA Sequencing Instruments (2005-2012) -North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 30: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Bio-Informatics

Exhibit 31: DNA Sequencing in Bio-Informatics (2005-2012) -North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 32: DNA Sequencing in Bio-Informatics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Europe

Exhibit 33: DNA Sequencing (2005-2012) - European Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Major Companies in Europe

Advalytix AG (Germany)

bioMérieux SA (France)

Biotage AB (Sweden)

Cytocell Technologies Ltd. (UK)

Dako A/S (Denmark)

DNAVision SA (Belgium)

Eppendorf AG (Germany)

Eurofins Medigenomix GmbH (Germany)

Exiqon A/S (Denmark)

Febit Biotech GmbH (Germany)

Geneart AG (Germany)

Kreatech Holding B.V (The Netherlands)

Microsynth AG (Switzerland)

MilleGen SA (France)

MWG Biotech AG (Germany)

Qiagen NV (The Netherlands)

Tepnel Life Sciences plc (UK)

Wellcome Trust Sanger Institute (The) (UK)

Analysis by Method

Automated DNA Sequencing

Exhibit 34: Automated DNA Sequencing (2005-2012) - European Market Analysis (Current and Future) by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 35: Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe

Non-Automated DNA Sequencing

Exhibit 36: Non-Automated DNA Sequencing (2005-2012) - European Market Analysis (Current and Future) by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 37: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe

Analysis by Application

Medical Research

Exhibit 38: DNA Sequencing in Medical Research (2005-2012) - European Market Analysis (Current and Future) by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 39: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe

Agriculture & Animal Husbandry

Exhibit 40: DNA Sequencing in Agriculture & Animal Husbandry (2005-2012) - European Market Analysis (Current and Future) by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 41: DNA Sequencing Agriculture & Animal Husbandry (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe

DNA Testing & Forensics

Exhibit 42: DNA Sequencing in Testing and Forensics (2005-2012) - European Market Analysis (Current and Future) by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 43: DNA Sequencing in Testing and Forensics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe

Analysis by Instruments/Software

Instruments

Exhibit 44: DNA Sequencing Instruments (2005-2012) -European Market Analysis (Current and Future) by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 45: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe

Bio-Informatics

Exhibit 46: DNA Sequencing in Bio-Informatics (2005-2012) -European Market Analysis (Current and Future) by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 47: DNA Sequencing in Bio-informatics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, UK, France, Switzerland and Rest of Europe

Asia-Pacific

Exhibit 48: DNA Sequencing (2005-2012) - Asia-Pacific Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Major Companies in Asia-Pacific

AgriGen Biotech Pty Ltd. (Australia)

Avestha Gengraine Technologies Pvt. Ltd. (India)

BGI Life Tech Co., Ltd. (China)

Bioneer, Inc. (South Korea)

Genetic Technologies Limited (Australia)

GeneWorks Pty. Ltd. (Australia)

GVK BIO (India)

Ocimum Biosolutions Ltd. (India)

Research Biolabs Pte Ltd. (Singapore)

Sangon Biological Engineering Technology & Services Co., Ltd. (China)

Saturn Biotech Ltd. (Australia)

Analysis by Method

Automated DNA Sequencing

Exhibit 49: Automated DNA Sequencing (2005-2012) -Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 50: Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Non-Automated DNA Sequencing

Exhibit 51: Non-Automated DNA Sequencing (2005-2012) -Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 52: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Analysis by Application

Medical Research

Exhibit 53: DNA Sequencing in Medical Research (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 54: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Agriculture & Animal Husbandry

Exhibit 55: DNA Sequencing in Agriculture & Animal Husbandry (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, ndia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 56: DNA Sequencing Agriculture & Animal Husbandry (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

DNA Testing & Forensics

Exhibit 57: DNA Sequencing in Testing and Forensics (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 58: DNA Sequencing in Testing and Forensics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Analysis by Instruments/Software

Instruments

Exhibit 59: DNA Sequencing Instruments (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)

Exhibit 60: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Bio-Informatics

Exhibit 61: DNA Sequencing in Bio-Informatics (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 62: DNA Sequencing in Bio-Informatics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Japan

Exhibit 63: DNA Sequencing (2005-2012) - Japanese Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Major Companies in Japan

Hokkaido System Science Co., Ltd.

Shimadzu Corporation

Rest of World

Exhibit 64: DNA Sequencing (2005-2012) - Rest of World Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Major companies in Rest of World

Hy Laboratories Ltd. (Israel)

Inqaba Biotechnical Industries (Pty) Ltd. (South Africa)

III. PRODUCT/TECHNOLOGY RESEARCH

1. Introduction

Replication of DNA

Protein Synthesis and DNA

Isolation and Amplification of DNA

Gel electrophoresis of DNA

Sequencing DNA

Polymerase Chain Reaction - Xeroxing DNA

The Principle behind PCR

The Technique Explained

Optimizing the PCR

Variations on the Basic PCR Technique

Allele-Specific PCR

Assembly PCR

Asymmetric PCR

Colony PCR

Helicase-dependent Amplification

Hot-start PCR

Intersequence Specific (ISSR) PCR

Inverse PCR

Ligation-Mediated PCR

Methylation Specific PCR

Multiplex Ligation-dependent Probe Amplification (MLPA)

Multiplex-PCR

Nested PCR

Quantitative PCR

RT-PCR

TAIL-PCR

Touchdown PCR

Electrophoretic Techniques

Properties and Applications of Supporting Media

Paper Electrophoresis

Cellulose Acetate Electrophoresis

Thin Layer Electrophoresis

Gel Electrophoresis

Types of Electrophoretic Techniques

High Voltage Electrophoresis

Continuous Electrophoresis

Discontinuous (Disc) Electrophoresis

Immunoelectrophoresis

Isoelectric Focusing

Two-dimensional Gel Electrophoresis

Pulsed Field Gel Electrophoresis (PFGE)

Isotachphoresis

DNA Sequencing Growth Trends - Global Markets

Exhibit 65: Global Market for DNA Sequencing: Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

DNA Sequencing - Methods and Technologies

DNA Sequencing Basics

Fragment Sequencing

Sequence Assembly

Database Processing

Genotyping and Linkage Analysis

Traditional Methods

The Four Best Known DNA Sequencing Techniques

Sanger Method and its Most Important Variants (Enzymatic Methods)

Sanger DNA Sequencing Simulation

Chain-Termination Method

Maxam and Gilbert Method

Dye-Terminator Sequencing

Pyrosequencing

Principle of Pyrosequencing

Strengths of Pyrosequencing

Protocols for DNA Sequencing

Bst-catalyzed Radiolabeled DNA Sequencing

Radiolabeled Sequencing Gel Preparation, Loading and Electrophoresis

Taq-Polymerase Catalyzed Cycle Sequencing Using Fluorescent-Labeled Dye Primers

Taq-Polymerase Catalyzed Cycle Sequencing Using Fluorescent-Labeled

Dye Terminator Reactions

Fluorescent-Labeled Sequencing Gel Preparation, Pre-Electrophoresis, Sample Loading,

Electrophoresis, Data Collection, and Analysis on the ABI 373A DNA Sequencer

Double-Stranded Sequencing of cDNA Clones Containing Long Poly(A)

Tails Using Anchored Poly(Dt) Primers

cDNA Sequencing Based on PCR and Random Shotgun Cloning

DNA Sequencing- Service Providing Methods

Basic DNA Sequencing

Standard DNA Sequencing

Ready-Run DNA Sequencing

Direct PCR DNA Sequencing

Special DNA Sequencing Services

TA Clone DNA Sequencing

Confirmation DNA Sequencing

FDA Quality DNA Sequencing

Mutation Discovery DNA Sequencing

SNP Discovery DNA Sequencing

Introduction to Shotgun Sequencing

Method Involved in Shotgun Sequencing

Working Procedure

Importance of Whole Genome Shotgun Sequencing

Latest Developments and Sophistications in the Field of Shotgun Sequencing

2. DNA Sequencing Methods

Growth Trends - Global DNA Sequencing by Methods

Exhibit 66: Global Market for DNA Sequencing: Methods (Automated and Non-Automated) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Automated

Growth Trends - Global Market for Automated DNA Sequencing

Exhibit 67: Global Market for Automated DNA Sequencing : Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Automated Sequencing

Cycle Sequencing Technique

Principle of DNA Sequencing

Denaturation

Annealing

Extension

Molecule Separation

Detection on an Automated Sequencer

Asembling the Sequenced Parts of a Gene

Automated Sequencer

Automated Sequencing with Fluorescent Dyes

Need for Automated Sequencing

Refinements in Automation

Waste Minimization Procedure

Advantages

Disadvantages

Automated Sequencing Gel

Automated DNA Sequencing Guidelines

Host Strain Recommendations

General Information about Templates

DNA Isolation Kits

GC Rich Templates

Non-Automated

Growth Trends - Global Market for Non-Automated DNA Sequencing

Exhibit 68: Global Market for Non-Automated DNA Sequencing : Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

3. DNA Sequencing Applications

Growth Trends - Global Market for DNA Sequencing by Applications

Exhibit 69: Global Market for DNA Sequencing: Applications (DNA Testing/Forensics, Agriculture/Animal Husbandry and Medical Research) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Medical Research

Growth Trends - Global Market for DNA Sequencing in Medical Research

Exhibit 70: Global Market for DNA Sequencing in Medical Research: Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

DNA Sequencing in Medical Research

Discovering a Drug

Understanding the Mechanism of a Disease

What are Genetic Disorders?

Identification of Target for Aiming Drug Discovery

Role of Functional Genomics in Drug Discovery

Target Validation

Applications of DNA Sequencing

Drug Discovery and Development-The Cost Angle

Genotyping and SNPs

High-Throughput Genotyping Technology

Implications of Drug Discovery and Deveopment

Proteomics

Pharmacogenomics

Benefits of Pharmacogenomics

More Powerful Medicines

Better, Safer Drugs - The First Time

More Accurate Methods of Determining Appropriate Drug Dosages

Advanced Screening for Disease

Better Vaccines

Improvements in the Drug Discovery and Approval Process

Decrease in the Overall Cost of Health Care

Developments in Pharmacogenomics

Pharmacogenomics Holds Tremendous Potential

Sequencing the Pieces of Pharmacogenomics and Drug Development

Impact of Pharmacogenomics on Clinical Trials

More Effective Pharmaceuticals

Genetic Testing, Therapy

Pharmacogenomics for Today

Pharmacogenomics for Lung Cancer

Pharmacogenomics - Finding the Competitive Edge for Genetic Variation

Field of Molecular Diagnostics

Agriculture & Animal Husbandry

Growth Trends - Global Market for DNA Sequencing in Agriculture and Animal Husbandry

Exhibit 71: Global Market for DNA Sequencing in Agriculture & Animal Husbandry: Geographic Regions (Rest of World, Asia-Pacific, Japan, Europe and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Genomics and Biotechnology in Agricultural Industry

DNA Sequencing in Animal Husbandry

Introduction

Advantages of DNA-based Products

DNA Sequencing in Cattle

DNA Markers to Improve Milk Production in Cattle

DNA Sequencing of Cattle Disease Agents

Sequencing of Microbes that Cause Leptospirosis

Transgenic Animals

Animal Welfare and the Environment

The use of Transgenic Animals to Improve Health of Human Beings

Domestic Animal Genomics

Bovine Genome Sequencing Project

Genome Project Promises a Beef Production Revolution

The Effect of Genetics and Genomics in Improving Beef Quality

Effect of Breeding on Beef Quality

Monogenic Inheritance of Beef Quality: The Double Muscling Character

Polygenic Inheritance of Beef Quality

Trans-Tasman Super Cow

Sheep Genomics

The Kangaroo Genome

Use of Marsupials in Comparative Genomics

The Kangaroo Genome Project

Poultry

Gene Expression Profiling and the Discovery of Functional Genomics of Poultry

DNA Sequencing of an Avian Septicemic strain of Eschrichia coli

New Developments in Poultry Breeding

Sequencing of the Chicken Genome

Use of Genetic Information in Breeding Programs

Genomics - Poultry Breeding and the Poultry Industry

Horse Genome Sequence

Equine Herpesvirus-1 Neurological Disease (EHV-1)

DNA Sequencing in Pig

Uses of a Genome Map

Application of DNA Sequencing in the Field of Aquaculture

Introduction and Overview

Development of Potential Brood Stock and Steps to Improve

Application of Transgenic Technology in Aquaculture Development

Vital statistics of DNA Sequencing in Intensive Aquaculture

Benefits Derived by Using DNA Sequencing in the Field of Mariculture

Application of Transgenic Fish to Better Understand the Various Aspects of

Environment

Commercial Culturing of Transgenic Fish

Application of transgenic Fish as Model Animal in environmental Toxicology

Deriving Vitamin C from Transgenic Fish

Use of Aplysia Sequencing in Various Scientific Fields as Model Organism

Culturing of Shrimp Genome

Study of Population Genetics of the Cave Shrimp Typhlatya

DNA Testing & Forensics

Growth Trends - Global Market for DNA Sequencing in Testing and Forensics

Exhibit 72: Global Market for DNA Sequencing in Testing and Forensics : Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

DNA Sequencing and its Application in Forensics

Introduction and Overview

Methods Adopted in Forensic Identification

DNA Sequencing Considered an Effective Means of Detecting Lineage and Parenthood

Application of DNA Technologies in Forensic Investigations

Polymerase Chain Reaction Analysis

Short Tandem Repeat (STR) Technology

Mitochondrial DNA Analysis to Analyze Matrilineal Lineage

Y-Chromosome an Important Indicator of Patrilineal Linage

DNA Forensics Databases

Concerns Pertaining to DNA Data Banking

Advantages of DNA Forensics

Effectiveness of DNA Fingerprinting

Application of DNA Fingerprinting in Human Health Studies

Benefits of DNA Fingerprints

Statistical Viewpoint of Interpretation of DNA Matching

Relevance of Forensic Archaeology in the Study of Forensics

DNA Forensics and Crime

Relating the Biological Evidence to Solve Criminal Cases

Advantages of Maintaining DNA Databases of Arrested Criminals

Requirements to Meet the Challenges of Bio-Terrorism

Trends Set by Forensic Anthropology in Crime Control

Identification and Treatment of Genetically Inherited Disorders

Identification of Individuals

Function of Microbial Forensics

Benefits Attributed to the Use of Microbial Forensics

Varied Function of Forensic Entomology

Urban

Stored Products Forensics

Medico Legal Forensics Entomology

Characteristics of Forensic Pathology

DNA Testing

Introduction

Strongholds and Constraints of DNA Testing

Exquisite Sensitivity

Application to any Body Tissue

DNA Stability vis-à-vis Proteins

DNA Polymorphims

Tandemly Repeated DNA

Variability in Restriction Sites

Techniques for DNA Testing

Single Location DNA Fingerprinting

Multi-Positional DNA Fingerprinting

Applications of DNA Testing

4. DNA Sequencing Instruments/Software

Growth Trends - Global Market for DNA Sequencing by Instruments/Software

Exhibit 73: Global Market for DNA Sequencing: Instruments/Software (Instruments and Bio-Informatics) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Instruments

Growth Trends - Global Market for DNA Sequencing Instruments

Exhibit 74: Global Market for DNA Sequencing Instruments : Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
DNA Sequencer

Concept of DNA Microarray Technology

Principle and Role in Molecular Diagnostics

Relation Between Probes and Array Development

Process of Target Labelling in Co-ordination with Detection Systems

Prospective Application of DNA Microarray in Veterinary Diagnostics

Various Applications of DNA Microarrays

Gene Expression Profiling of mRNA

Comparative Genomic Hybridization (CGH)

SNP Detection Arrays

Chromatin Immuno Precipitation (chIP) Studies

Types of Microarrays

Spotted Microarrays

Oligonucleotide Microarrays

Genotyping Microarrays

Micro Fluidic Devices

Reagents Used in the Sequencing of DNA

Functions and Uses of DNA Synthesizer

Applications

Bio-Informatics

Growth Trends - Global Market for DNA Sequencing in Bio-Informatics

Exhibit 75: Global Market for DNA Sequencing in Bio-Informatics: Geographic Regions (Japan, Asia-Pacific, Rest of World, Europe and North America) Ranked by Projected CAGR for 2005 through 2012

Bio-Informatics

Divisions

Data Generation

Database Organisation

Data Examination

Data Association

Integrated Data Analysis

Database Analysis

Drug Discovery and Bio-informatics

DNA Sequencing - Research and Development

DNA Mapping

Chromosome Walking

DNA Sequencing in Microbiology

Introduction

Achievements

Highly Developed Sequencing Technologies and Their Influence in Microbiology

DNA Sequencing in Probiotics

Identification of Probiotic Microorganisms in PCR-Based Analysis

Sequencing and Sequence Analysis

Molecular Based Approaches to Soil Microbiology

Deciphering of the Microorganisms

Advancements in Molecular Diagnostic Techniques

Genetic Amplification

Manufacturing of Highly Potent Antibiotics and Vaccinations

Possible Developments

Genome Sequencing in Microbes

Genome shotgun Sequencing of the Sargasso Sea

Community Sequencing Program

Understanding of Human Biology and Disease

Microbial Genome Sequencing

Understanding of Microbial Pathogenesis

Screening for Virulence Genes

Human Genome Project

Prokaryotes and Eukaryotes

Chromosomes

Genome

Eukaryotic Genome

C-Value Paradox

Origin of HGP

Genome Sequencing

Goals of HGP

Outcome of HGP

Ethical Issues

Functional Genomics

History of HGP

Mapping the Genome from a Human Perspective

Assembly of Human Genome

Research Sequence

Functional Characteristics

DNA Sequencing Sets its Sights on the Future

Human Genome

Human DNA Sequence

Human Genome Sequence Variation

IV. MARKET DYNAMICS

1. Market Overview

Purpose of DNA Sequencing

Global Market Analysis

Exhibit 76: DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 77: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World (Graphical Representation Included)

Global Market Analysis by Segmentation

Analysis by Method

Exhibit 78: DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Billion (Graphical Representation Included)

Exhibit 79: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Method for Automated and Non-Automated (Graphical Representation Included)

Non-Automated Methods

Exhibit 80: Non-Automated DNA Sequencing (2005-2012) - Global Market Analysis (Current & Future) by Methods for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Billion (Graphical Representation Included)

Exhibit 81: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Method for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 82: DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) by Application for Medical Research, Agriculture / Animal Husbandry and DNA Testing/Forensics in US$ Billion (Graphical Representation Included)

Exhibit 83: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Application for Medical Research, Agriculture / Animal Husbandry and DNA Testing / Forensics (Graphical Representation Included)

Medical Research Applications

Exhibit 84: DNA Sequencing in Medical Research (2005-2012) - Global Market Analysis (Current and Future) by Application for Molecular Diagnostics, Pharmacogenomics and Proteomics in US$ Billion (Graphical Representation Included)

Exhibit 85: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Application for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 86: DNA Sequencing (2005-2012) - Global Market Analysis (Current and Future) by Instruments/Software for Instruments and Bioinformatics in US$ Billion (Graphical Representation Included)

Exhibit 87: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Instruments/Software for Instruments and Bioinformatics (Graphical Representation Included)

DNA Sequencing Instruments

Exhibit 88: DNA Sequencing Instruments (2005-2012) - Global Market Analysis (Current & Future) by DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Billion (Graphical Representation Included)

Exhibit 89: DNA Sequencing Instruments (2005, 2009 and 2012) - Percentage Breakdown of Global Instruments Market Value by DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

2. Major Global Companies in DNA Sequencing Industry

454 Life Sciences (USA)

Abbott Laboratories (USA)

Advalytix AG (Germany)

Affymetrix, Inc. (USA)

Agencourt Bioscience Corporation (USA)

Agilent Technologies (USA)

AgriGen Biotech Pty Ltd. (Australia)

Applied Biosystems Group (USA)

Avestha Gengraine Technologies Pvt. Ltd. (India)

BD Biosciences (USA)

Beckman Coulter, Inc. (USA)

BGI Life Tech Co., Ltd. (China)

bioMérieux SA (France)

Bioneer, Inc. (South Korea)

Biotage AB (Sweden)

BioTrove, Inc. (USA)

Cogenics (A Division of Clinical Data) (USA)

Commonwealth Biotechnologies, Inc. (USA)

Crime Scene Technologies LLC (USA)

Cytocell Technologies Ltd. (UK)

Dako A/S (Denmark)

DNA LandMarks, Inc. (Canada)

DNAVision SA (Belgium)

Epicentre Biotechnologies (USA)

Eppendorf AG (Germany)

Eurofins Medigenomix GmbH (Germany)

Exiqon A/S (Denmark)

Febit Biotech GmbH (Germany)

Gene Logic, Inc. (USA)

Geneart AG (Germany)

Genetic Technologies Limited (Australia)

GeneWorks Pty. Ltd. (Australia)

Gen-Probe, Inc. (USA)

GVK BIO (India)

Helicos BioSciences Corporation (USA)

Hokkaido System Science Co., Ltd. (Japan)

Hy Laboratories Ltd. (Israel)

Illumina, Inc. (USA)

Integrated DNA Technologies, Inc. (USA)

Invitrogen, Inc. (USA)

Inqaba Biotechnical Industries (Pty) Ltd. (South Africa)

Kreatech Holding B.V (The Netherlands)

Luminex Molecular Diagnostics (Canada)

Microsynth AG (Switzerland)

MilleGen SA (France)

MWG Biotech AG (Germany)

Nimblegen Systems, Inc. (USA)

Ocimum Biosolutions Ltd. (India)

PrimmBiotech, Inc. (USA)

Promega Corp. (USA)

Qiagen NV (The Netherlands)

Research Biolabs Pte Ltd. (Singapore)

Sangon Biological Engineering Technology & Services Co., Ltd. (China)

Saturn Biotech Ltd. (Australia)

Sequetech Corp. (USA)

Shimadzu Corp. (Japan)

Tepnel Life Sciences plc (UK)

Third Wave Technologies, Inc. (USA)

Wellcome Trust Sanger Institute (The) (UK)

3. Major Activities in DNA Sequencing Industry

OncoMethylome Sciences Offers DNA Profiling Services under Collaboration to Abbott Oncology Compounds

Affymetrix Signs Agreement to Acquire USB Corporation

Agencourt® Genomic Services to use Applied Biosystems’ SOLiD System in New DNA Sequencing Services

Febit in association with Prognosys Biosciences Integrates Latest

DNA Sequencing and Microarray Technology

Agilent Technologies and BioNanomatrix Combine Technologies for Designing a New Genetic Analysis System

Applied Biosystems to Co-develop Applications using Olink’s Proximity Ligation Assay (PLA)

Technology

BioTrove to Supply OpenArray™ Technology to OncoMethylome Sciences

Roche Purchases Entire Stake in 454 Life Sciences

Cellectis Associates with Bayer CropScience for the Application of Meganuclease

Technology in Plants…

Cytogenix Join Hands with Eurogentec for the Development of Syndna™ …

Syngenta Collaborates with Biotrove for Enhanced Seed Breeding Employing

Genomics Technology …

BioServe Signs an Agreement with SeraCare to Acquire Genomics…

GATC Biotech Develops Novel DNA Sequencing Technique…

Agencourt Enters into Alliance with Affymetrix Clinical Services Lab and NuGEN Technologies for Enhancing the Automated Clinical Whole Blood Sample Expression Profiling…

Cambridge Antibody Technology Enters into Alliance with Philochem for the Application of DNA-Encoded Libraries…

Clinical Data and Epigenetic Join Hands to offer DNA Methylamine Services…

UC-Davis School of Medicine Employs Biotrove’s Openarray™ Technology to Discover the Genetic Variation Association with Common Disease in Humans…

Genencor Enters into an Agreement with Integrated Genomics to License Ergo System…

Cepheid Purchases Stake in Sangtec for Strengthening R&D and Manufacturing Facility

Geneservice Purchases DNA Sequencing Facility Located at Biochemistry Department, University of Oxford

SanAir Technologies Incorporates DNA Sequencing Technology for the Identification of Dangerous Microbes…

Applied Biosystems and Eagle Collaborate to advance the Single Molecule Detection Device

MWG Biotech Purchases Eurofins Medigenomix for Rapid DNA Sequencing Service…

bioMérieux Inc., Buys Bacterial Barcodes Inc., the Patent Holder of Pioneering

Genotyping Technology

Bio-Rad Join Hands with Integrated DNA Technologies for Developing RNAi Tool Sets…

Cellectis Receives License to Employ Lexicon Genetics' Isogenic DNA Technology Globally…

Applied Biosystems Acquires Agencourt Personal Genomics…

Beckman Coulter Acquires In Vitro Diagnostics Product Licenses to Roche’s Portfolio of Real-Time Polymerase Chain Reaction Patents

Geneservice Ltd., Receives Credit as one of the Top-Three Dna Sequencing Suppliers to The Medical Research Council…

Antibodies By Design Partners with Japan’s Kazusa DNA Research Institute for Developing Antibody Series

Reveo in Association with University of Washington Develops Cost-Effective

DNA Sequencing Technology…

LGC Acquires Berlin Based AGOWA…

4. Major Product Innovations/Launches in DNA Sequencing Industry

Sigma-Aldrich Introduces Imprint™ Kit Based on Bisulfite DNA Modification Technology

Applied Biosystems Introduces SOLiD™ System, the New Era DNA Sequencing Platform

Roche NimbleGen Introduces 4-plex Gene Expression Arrays and Services

Spartan Bioscience Unveils The Spartan DX, the High-tech PCR DNA Analyzer

Applied Biosystems Unveils Novel Variant Reporter™ Software for Biomedical Researchers

Chromatin Attains Novel Patents for Plant Mini-Chromosome Technology

ABI Introduces SOLiD Gene Sequencer

Agilent Technologies Introduces High-Capacity Enrichment, Intact Protein Chips

DNA Sequencing Kit from Baseclear

Agilent Technologies Launches 8-Plex High-Density Microarrays

Decode Unveils a New DNA-Based Test for Evaluating the Threat Associated with

Type 2 Diabetes

AGOWA Unveils Advanced DNA Extraction Kits

Applied Biosystems Launches PCR Amplification Kit Perfect for Application With Old, Damaged DNA Samples

New DNA chip for Ashkenazi Jewish diseases

Transgenomic’s novel DNA Mutation Detection Kits for Application in Whole Primer Fluorescent Capillary Electrophoresis

Norgen Biotek Releases Kit for Simultaneous Purification of RNA, DNA, and Proteins from Single Sample

Abbott Unveils the Novel DNA Tests (CE-Marked) in Europe

Gene Codes Introduce Advanced Version of Sequencher

Applied Biosystems Launches Novel Methyl Primer Express® Software

Nugen Technologies Designs Novel Products for cDNA Studies and mRNA Amplification

Celera’s CE Mark a New Real Time PCR HCV Genotyping Test to be marketed in the EU

Beckman Coulter Launches Agencourt® FormaPure™ System

Now Improved ELISA Assays in just 18 weeks

Velocity11 Launches Novel Microplate Sealing Films

Vandalia Research Introduces Solution for Custom DNA Amplification based on PCR…

Qiagen Unveils Novel Bisulfite Kit for Application in DNA Methylation Analysis…

454 Life Sciences and Roche Diagnostics Launch Advanced Range of

Genome Sequencer 20™ System

Biotage Introduces Novel Range of Advanced Solutions Incorporating the

Pyrosequencing® platforms

SoftGenetics Incorporates Novel Feature Mutation Surveyor Software…

Solexa Unveils the New Genome Analysis System for DNA Sequencing,

Expression Profiling, RNA Analysis

5. Regional Market Analysis

A. North America

Analysis by Geographic Region

Exhibit 90: DNA Sequencing (2005-2012) -North American Market Analysis (Current and Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 91: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Exhibit 92: List of Major Companies in North America

Analysis by Method

Exhibit 93: DNA Sequencing (2005-2012) -North American Market Analysis (Current and Future) by Method for (Automated and Non-Automated) in US$ Billion (Graphical Representation Included)

Exhibit 94: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 95: Non-Automated DNA Sequencing (2005-2012) -North American Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Billion (Graphical Representation Included)

Exhibit 96: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 97: DNA Sequencing (2005-2012) -North American Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Billion (Graphical Representation Included)

Exhibit 98: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research Application

Exhibit 99: DNA Sequencing in Medical Research (2005-2012) - North American Market Analysis by Application (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Billion (Graphical Representation Included)

Exhibit 100: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Application in Medical Research for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 101: DNA Sequencing (2005-2012) -North American Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Billion (Graphical Representation Included)

Exhibit 102: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 103: DNA Sequencing Instruments (2005-2012) - North American Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Billion (Graphical Representation Included)

Exhibit 104: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value Instruments for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

A1. The United States

Exhibit 105: DNA Sequencing (2005-2012) -United States Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Analysis by Method

Exhibit 106: DNA Sequencing (2005-2012) -United States Market Analysis (Current and Future) by Method for (Automated and Non-Automated) in US$ Billion (Graphical Representation Included)

Exhibit 107: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 108: Non-Auotmated DNA Sequencing (2005-2012) -United States Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Billion (Graphical Representation Included)

Exhibit 109: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Applications

Exhibit 110: DNA Sequencing (2005-2012) -United States Market Analysis (Current and Future) by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics in US$ Billion (Graphical Representation Included)

Exhibit 111: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research Application

Exhibit 112: DNA Sequencing in Medical Research (2005-2012) - United States Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Billion (Graphical Representation Included)

Exhibit 113: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 114: DNA Sequencing (2005-2012) -United States Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Billion (Graphical Representation Included)

Exhibit 115: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 116: DNA Sequencing Instruments (2005-2012) - United States Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Billion (Graphical Representation Included)

Exhibit 117: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

A2. Canada

Exhibit 118: DNA Sequencing (2005-2012) -Canadian Market Analysis (Current and Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 119: DNA Sequencing (2005-2012) - Canadian Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 120: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated DNA Sequencing

Exhibit 121: Non-Automated DNA Sequencing (2005-2012) - Canadian Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 122: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 123: DNA Sequencing (2005-2012) - Canadian Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 124: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 125: DNA Sequencing in Medical Research (2005-2012) - Canadian Market Analysis by Application (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 126: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 127: DNA Sequencing (2005-2012) - Canadian Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 128: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 129: DNA Sequencing Instruments (2005-2012) - Canadian Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 130: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

B. EUROPE

Analysis by Geographic Region

Exhibit 131: DNA Sequencing (2005-2012) -European Market Analysis (Current and Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)

Exhibit 132: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe

Exhibit 133: List of Major Companies in Europe

Analysis by Method

Exhibit 134: DNA Sequencing (2005-2012) -European Market Analysis (Current and Future) by Method for (Automated and Non-Automated) in US$ Billion (Graphical Representation Included)

Exhibit 135: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method of DNA Sequencing

Exhibit 136: Non-Automated DNA Sequencing (2005-2012) - European Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 137: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of European Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 138: DNA Sequencing (2005-2012) - European Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Billion (Graphical Representation Included)

Exhibit 139: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 140: DNA Sequencing in Medical Research (2005-2012) - European Market Analysis by Application (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Billion (Graphical Representation Included)

Exhibit 141: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of European Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 142: DNA Sequencing (2005-2012) - European Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Billion (Graphical Representation Included)

Exhibit 143: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 144: DNA Sequencing Instruments (2005-2012) - European Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Billion (Graphical Representation Included)

Exhibit 145: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of European Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

B1. Germany

German Market Analysis

Exhibit 146: DNA Sequencing (2005-2010) -German Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 147: DNA Sequencing (2005-2012) -German Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 148: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 149: Non-Automated DNA Sequencing (2005-2012) - German Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 150: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of German Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 151: DNA Sequencing (2005-2012) - German Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 152: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 153: DNA Sequencing in Medical Research (2005-2012) - German Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 154: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of German Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 155: DNA Sequencing (2005-2012) - German Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 156: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 157: DNA Sequencing Instruments (2005-2012) - German Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 158: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of German Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

B2. The United Kingdom

United Kingdom Market Analysis

Exhibit 159: DNA Sequencing (2005-2010) -United Kingdom Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 160: DNA Sequencing (2005-2012) - United Kingdom Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 161: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 162: Non-Automated DNA Sequencing (2005-2012) -United Kingdom Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 163: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 164: DNA Sequencing (2005-2012) -United Kingdom Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 165: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 166: DNA Sequencing in Medical Research (2005-2012) -United Kingdom Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 167: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 168: DNA Sequencing (2005-2012) -United Kingdom Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 169: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 170: DNA Sequencing Instruments (2005-2012) -United Kingdom Market Analysis (Current and Future) Instruments for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 171: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

B3. France

French Market Analysis

Exhibit 172: DNA Sequencing (2005-2010) -French Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 173: DNA Sequencing (2005-2012) - French Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 174: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 175: Non-Automated DNA Sequencing (2005-2012) - French Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 176: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of French Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 177: DNA Sequencing (2005-2012) - French Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 178: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 179: DNA Sequencing in Medical Research (2005-2012) - French Market Analysis by Application (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 180: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of French Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 181: DNA Sequencing (2005-2012) - French Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 182: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 183: DNA Sequencing Instruments (2005-2012) - French Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 184: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of French Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

B4. Switzerland

Swiss Market Analysis

Exhibit 185: DNA Sequencing (2005-2010) - Swiss Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 186: DNA Sequencing (2005-2012) - Swiss Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 187: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Method for Automated and Non-Automated.

Analysis by Non-Automated Method

Exhibit 188: Non-Automated DNA Sequencing (2005-2012) - Swiss Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 189: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 190: DNA Sequencing (2005-2012) - Swiss Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 191: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research Applications

Exhibit 192: DNA Sequencing in Medical Research (2005-2012) - Swiss Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 193: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 194: DNA Sequencing (2005-2012) - Swiss Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 195: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 196: DNA Sequencing Instruments (2005-2012) - Swiss Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 197: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

B5. Rest of Europe

Rest of Europe Market Analysis

Exhibit 198: DNA Sequencing (2005-2010) - Rest of Europe

Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 199: DNA Sequencing (2005-2012) - Rest of Europe Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 200: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 201: Non-Automated DNA Sequencing (2005-2012) - Rest of Europe Market Analysis (Current and Future) by Method for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 202: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Method for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 203: DNA Sequencing (2005-2012) - Rest of Europe Market Analysis (Current and Future) by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 204: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research Application

Exhibit 205: DNA Sequencing in Medical Research (2005-2012) - Rest of Europe Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 206: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 207: DNA Sequencing (2005-2012) - Rest of Europe Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 208: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 209: DNA Sequencing Instruments (2005-2012) - Rest of Europe Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 210: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

C. ASIA-PACIFIC

Analysis by Geographic Region

Exhibit 211: DNA Sequencing (2005-2012) -Asia-Pacific Market Analysis (Current and Future) by Geographic Region for Australia, China, India and Rest of Asia in US$ Billion (Graphical Representation Included)

Exhibit 212: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia (Graphical Representation Included)

Exhibit 213: List of Major Companies in Asia-Pacific

Analysis by Method

Exhibit 214: DNA Sequencing (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Billion (Graphical Representation Included)

Exhibit 215: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 216: Non-Automated DNA Sequencing (2005-2012) - Asia-Pacific Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 217: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 218: DNA Sequencing (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Billion (Graphical Representation Included)

Exhibit 219: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 220: DNA Sequencing in Medical Research (2005-2012) - Asia-Pacific Market Analysis by Application (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 221: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 222: DNA Sequencing (2005-2012) - Asia-Pacific Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Billion (Graphical Representation Included)

Exhibit 223: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 224: DNA Sequencing Instruments (2005-2012) - Asia-Pacific Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Billion (Graphical Representation Included)

Exhibit 225: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Instruments for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

C1. Australia

Australian Market Analysis

Exhibit 226: DNA Sequencing (2005-2010) -Australian Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 227: DNA Sequencing (2005-2012) - Australian Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 228: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 229: Non-Automated DNA Sequencing (2005-2012) - Australian Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 230: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 231: DNA Sequencing (2005-2012) - Australian Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 232: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research

Exhibit 233: DNA Sequencing in Medical Research (2005-2012) - Australian Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 234: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 235: DNA Sequencing (2005-2012) - Australian Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 236: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 237: DNA Sequencing Instruments (2005-2012) - Australian Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 238: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

C2. China

Chinese Market Analysis

Exhibit 239: DNA Sequencing (2005-2010) - Chinese Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 240: DNA Sequencing (2005-2012) - Chinese Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 241: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 242: Non-Automated DNA Sequencing (2005-2012) - Chinese Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million

Exhibit 243: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other

Analysis by Application

Exhibit 244: DNA Sequencing (2005-2012) - Chinese Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 245: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research

Exhibit 246: DNA Sequencing in Medical Research (2005-2012) - Chinese Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 247: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 248: DNA Sequencing (2005-2012) - Chinese Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 249: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 250: DNA Sequencing Instruments (2005-2012) - Chinese Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 251: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

C3. India

Indian Market Analysis

Exhibit 252: DNA Sequencing (2005-2010) - Indian Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 253: DNA Sequencing (2005-2012) - Indian Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 254: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 255: Non-Automated DNA Sequencing (2005-2012) - Indian Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 256: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 257: DNA Sequencing (2005-2012) - Indian Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 258: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research

Exhibit 259: DNA Sequencing in Medical Research (2005-2012) - Indian Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 260: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 261: DNA Sequencing (2005-2012) - Indian Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 262: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 263: DNA Sequencing Instruments (2005-2012) - Indian Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 264: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

C4. Rest of Asia-Pacific

Rest of Asia-Pacific Market Analysis

Exhibit 265: DNA Sequencing (2005-2010) - Rest of Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Method

Exhibit 266: DNA Sequencing (2005-2012) - Rest of Asia-Pacific Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 267: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Method for Automated and Non-Automated (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 268: Non-Automated DNA Sequencing (2005-2012) - Rest of Asia-Pacific Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 269: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 270: DNA Sequencing (2005-2012) - Rest of Asia-Pacific Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 271: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics

Analysis by Medical Research

Exhibit 272: DNA Sequencing in Medical Research (2005-2012) - Rest of Asia-Pacific Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 273: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 274: DNA Sequencing (2005-2012) - Rest of Asia-Pacific Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 275: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 276: DNA Sequencing Instruments (2005-2012) - Rest of Asia-Pacific Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 277: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

D. Japan

Japanese Market Analysis

Exhibit 278: DNA Sequencing (2005-2012) - Japanese Market Analysis (Current and Future) in US$ Million (Graphical Representation Included)

Exhibit 279: List of Major Companies in Japan

Analysis by Method

Exhibit 280: DNA Sequencing (2005-2012) - Japanese Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Million (Graphical Representation Included)

Exhibit 281: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Method for Automated and Non-Automated (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 282: Non-Automated DNA Sequencing (2005-2012) - Japanese Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 283: Non-Autoamted DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 284: DNA Sequencing (2005-2012) - Japanese Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Million (Graphical Representation Included)

Exhibit 285: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 286: DNA Sequencing in Medical Research (2005-2012) - Japanese Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 287: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 288: DNA Sequencing (2005-2012) - Japanese Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio-Informatics in US$ Million (Graphical Representation Included)

Exhibit 289: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 290: DNA Sequencing Instruments (2005-2012) - Japanese Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 291: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

E. REST OF WORLD

Rest of World Market Analysis

Exhibit 292: DNA Sequencing (2005-2012) - Rest of World Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

Exhibit 293: List of Companies in Rest of World

Analysis by Method

Exhibit 294: DNA Sequencing (2005-2012) - Rest of World Market Analysis (Current and Future) by Method for Automated and Non-Automated in US$ Billion (Graphical Representation Included)

Exhibit 295: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Method for Automated and Non-Automated. (Graphical Representation Included)

Analysis by Non-Automated Method

Exhibit 296: Non-Automated DNA Sequencing (2005-2012) - Rest of World Market Analysis (Current and Future) for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other in US$ Million (Graphical Representation Included)

Exhibit 297: Non-Automated DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value for Sanger’s, Maxam-Gilbert, Pyrosequencing and Other (Graphical Representation Included)

Analysis by Application

Exhibit 298: DNA Sequencing (2005-2012) - Rest of World Market Analysis (Current and Future) by Application for Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics in US$ Billion (Graphical Representation Included)

Exhibit 299: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Application for Medical Research, Agriculture and Animal Husbandry and DNA Testing & Forensics (Graphical Representation Included)

Analysis by Medical Research

Exhibit 300: DNA Sequencing in Medical Research (2005-2012) - Rest of World Market Analysis (Current and Future) for Proteomics, Pharmacogenomics and Molecular Diagnostics in US$ Million (Graphical Representation Included)

Exhibit 301: DNA Sequencing in Medical Research (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value for Proteomics, Pharmacogenomics and Molecular Diagnostics (Graphical Representation Included)

Analysis by Instruments/Software

Exhibit 302: DNA Sequencing (2005-2012) - Rest of World Market Analysis (Current and Future) by Instruments/Software for Instruments and Bio Informatics in US$ Billion (Graphical Representation Included)

Exhibit 303: DNA Sequencing (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Instruments/Software for Instruments and Bio-Informatics (Graphical Representation Included)

Analysis by Instruments

Exhibit 304: DNA Sequencing Instruments (2005-2012) - Rest of World Market Analysis (Current and Future) for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology in US$ Million (Graphical Representation Included)

Exhibit 305: DNA Sequencing Instruments (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value for DNA Sequencers, DNA Sequencing Kits, DNA Synthesizers and Microarray Technology (Graphical Representation Included)

6. DNA Sequencing - The Industry Outlook

V. CORPORATE DIRECTORY

Abstract

This market insight report presents an in depth analysis of DNA Sequencing market. The study emphasizes on the Methods of DNA Sequencing and Instruments/Software used in DNA Sequencing for applications in Medical Research, Agriculture & Animal Husbandry, DNA Testing, and Forensics. Automated and Non-Automated (Sanger’s, Maxam-Gilbert and Pyrosequencing) DNA Sequencing Methods are analyzed. The major Instruments/Software segments encompass Instruments (DNA Sequencers, DNA Synthesizers, DNA Sequencing Kits, and Microarray Technology) and Bio-Informatics. Application analysis of Medical Research fields such as Proteomics, Pharmacogenomics and Molecular Diagnostics is also covered. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists 430 companies that are engaged in DNA Sequencing services, instrumentation, R&D and supply of products and services. Major Contract Research Organizations serving the global DNA Sequencing industry are also covered in the corporate directory section of this report. Projections and estimates are graphically represented by region, by technology and by product segment. A global perspective is presented along with regional analysis covering the regions of 305 exclusive exhibits.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008